Showing results (611-620 of 739) with videos related to

Sort By:
Pageof 74
NPJ Biofilms and Microbiomes|May 26, 2025
Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samplesSuravi Raychaudhuri, Hakan Gem, Kevin Chung, et al.
Clinical Pharmacokinetics|December 16, 2024
Population Pharmacokinetics of Meropenem Across the Adult LifespanAngelique E Boutzoukas, Stephen J Balevic, Marion Hemmersbach-Miller, et al.
Genetics|September 30, 2004
A microsatellite genetic linkage map for XiphophorusR B Walter, J D Rains, J E Russell, et al.
American Journal of Hematology|May 21, 2013
Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology GroupRoland B Walter, George S Laszlo, Todd A Alonzo, et al.
Annals of Epidemiology|April 30, 2024
Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023Adam Z Blatt, Mina Suh, Emmanuel B Walter, et al.
JAMA Network Open|November 6, 2024
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical TrialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine LymphomaShyril O'Steen, Sang Y Lee, Melissa L Comstock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Pageof 74